Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX7P8T
|
||||
Drug Name |
N-[1-(2S-Ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-4-(pyridine-3-sulfonylamino)-benzamide
|
||||
Synonyms |
CHEMBL480638
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H34N4O6S
|
||||
Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)c4cccnc4)cc3
|
||||
InChI |
InChI=1S/C27H34N4O6S/c1-3-23-24(22(32)17-37-23)30-26(34)21(15-27(2)12-4-5-13-27)29-25(33)18-8-10-19(11-9-18)31-38(35,36)20-7-6-14-28-16-20/h6-11,14,16,21,23-24,31H,3-5,12-13,15,17H2,1-2H3,(H,29,33)(H,30,34)/t21-,23-,24+/m0/s1
|
||||
InChIKey |
AVAXSGXOQJUXHZ-OEMFJLHTSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.